David Tyronne Howton, Jr
2016
In 2016, David Tyronne Howton, Jr earned a total compensation of $2.3M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,445 |
|---|---|
| Option Awards | $715,566 |
| Salary | $407,176 |
| Stock Awards | $996,553 |
| Other | $12,718 |
| Total | $2,327,458 |
Howton received $996.6K in stock awards, accounting for 43% of the total pay in 2016.
Howton also received $195.4K in non-equity incentive plan, $715.6K in option awards, $407.2K in salary and $12.7K in other compensation.
Rankings
In 2016, David Tyronne Howton, Jr's compensation ranked 4,219th out of 14,075 executives tracked by ExecPay. In other words, Howton earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,219 out of 14,075 | 70th |
Division Manufacturing | 1,475 out of 5,489 | 73rd |
Major group Chemicals And Allied Products | 444 out of 1,895 | 77th |
Industry group Drugs | 322 out of 1,538 | 79th |
Industry Pharmaceutical Preparations | 253 out of 1,176 | 79th |
Source: SEC filing on April 27, 2017.
Howton's colleagues
We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2016.
2016
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2016
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2016
Shamim Ruff
Sarepta Therapeutics
Senior Vice President, Regulatory Affairs and Quality
2016
Alexander Cumbo
Sarepta Therapeutics